First Time Loading...

Silence Therapeutics PLC
NASDAQ:SLN

Watchlist Manager
Silence Therapeutics PLC Logo
Silence Therapeutics PLC
NASDAQ:SLN
Watchlist
Price: 21.3 USD -0.56% Market Closed
Updated: May 3, 2024

Silence Therapeutics PLC
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Silence Therapeutics PLC
Cash from Operating Activities Peer Comparison

Comparables:
CNTA
AUTL
BCYC
IMCR
GNS

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Silence Therapeutics PLC
NASDAQ:SLN
Cash from Operating Activities
£1.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Cash from Operating Activities
-$160.3m
CAGR 3-Years
-147%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
Cash from Operating Activities
-$145.6m
CAGR 3-Years
-7%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bicycle Therapeutics PLC
NASDAQ:BCYC
Cash from Operating Activities
-$60.6m
CAGR 3-Years
-50%
CAGR 5-Years
-18%
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Cash from Operating Activities
£2.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
Cash from Operating Activities
£44.6m
CAGR 3-Years
-16%
CAGR 5-Years
4%
CAGR 10-Years
3%

See Also

What is Silence Therapeutics PLC's Cash from Operating Activities?
Cash from Operating Activities
1.7m GBP

Based on the financial report for Dec 31, 2019, Silence Therapeutics PLC's Cash from Operating Activities amounts to 1.7m GBP.